Chemclin Diagnostics Co., Ltd. (SHA:688468)
7.41
+0.17 (2.35%)
Apr 29, 2026, 3:00 PM CST
Chemclin Diagnostics Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2017 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2017 |
| Cash & Equivalents | 105.92 | 400.25 | 448.66 | 342.14 | 311.63 | Upgrade
|
| Trading Asset Securities | 301.22 | 509 | 470 | 643 | 613 | Upgrade
|
| Cash & Short-Term Investments | 407.14 | 909.25 | 918.66 | 985.14 | 924.63 | Upgrade
|
| Cash Growth | -55.22% | -1.02% | -6.75% | 6.54% | 67.08% | Upgrade
|
| Accounts Receivable | 12.93 | 20.31 | 25.29 | 34.06 | 35.13 | Upgrade
|
| Other Receivables | 3.49 | 3.87 | 6.48 | 2.94 | 3.21 | Upgrade
|
| Receivables | 16.42 | 24.18 | 31.77 | 37.01 | 38.34 | Upgrade
|
| Inventory | 110.05 | 109.26 | 110.61 | 112.56 | 122.36 | Upgrade
|
| Other Current Assets | 227.97 | 24.99 | 41.59 | 30.55 | 5.96 | Upgrade
|
| Total Current Assets | 761.59 | 1,068 | 1,103 | 1,165 | 1,091 | Upgrade
|
| Property, Plant & Equipment | 467.2 | 483.65 | 495.01 | 223.44 | 157.85 | Upgrade
|
| Goodwill | 153.76 | 153.76 | 153.76 | 153.76 | 153.76 | Upgrade
|
| Other Intangible Assets | 35.44 | 41.48 | 34.24 | 13.97 | 13.75 | Upgrade
|
| Long-Term Deferred Tax Assets | 31.79 | 31.51 | 22.08 | 15.17 | 10.7 | Upgrade
|
| Long-Term Deferred Charges | 48.73 | 54.08 | 12.84 | 19.59 | 3.55 | Upgrade
|
| Other Long-Term Assets | 262.43 | - | - | - | - | Upgrade
|
| Total Assets | 1,761 | 1,832 | 1,821 | 1,591 | 1,431 | Upgrade
|
| Accounts Payable | 22.96 | 66.63 | 90.24 | 67.75 | 22.03 | Upgrade
|
| Accrued Expenses | 8.6 | 17.99 | 22.22 | 38.88 | 24.13 | Upgrade
|
| Current Portion of Long-Term Debt | 49.16 | 20.19 | - | - | - | Upgrade
|
| Current Portion of Leases | - | 5.25 | 6.66 | 10.9 | 11.39 | Upgrade
|
| Current Income Taxes Payable | 7.05 | 4.88 | 9.61 | 16.48 | 9.28 | Upgrade
|
| Current Unearned Revenue | 13.06 | 9.6 | 6.91 | 4.58 | 3.57 | Upgrade
|
| Other Current Liabilities | 58.71 | 58.81 | 58.5 | 58.67 | 51.16 | Upgrade
|
| Total Current Liabilities | 159.54 | 183.35 | 194.13 | 197.25 | 121.56 | Upgrade
|
| Long-Term Debt | 160.19 | 200.19 | 196.67 | - | - | Upgrade
|
| Long-Term Leases | 22.62 | 24.12 | 31.28 | 1.57 | 13.22 | Upgrade
|
| Long-Term Unearned Revenue | 2.75 | - | - | - | 5 | Upgrade
|
| Long-Term Deferred Tax Liabilities | 4.95 | 8.18 | 9.68 | 11.77 | 12.46 | Upgrade
|
| Total Liabilities | 350.05 | 415.85 | 431.76 | 210.59 | 152.23 | Upgrade
|
| Common Stock | 401.11 | 401.11 | 401 | 401 | 401 | Upgrade
|
| Additional Paid-In Capital | 565.66 | 565.66 | 564.92 | 564.92 | 547.48 | Upgrade
|
| Retained Earnings | 495.22 | 500.63 | 422.88 | 414.65 | 330.2 | Upgrade
|
| Treasury Stock | -51.09 | -51.09 | - | - | - | Upgrade
|
| Shareholders' Equity | 1,411 | 1,416 | 1,389 | 1,381 | 1,279 | Upgrade
|
| Total Liabilities & Equity | 1,761 | 1,832 | 1,821 | 1,591 | 1,431 | Upgrade
|
| Total Debt | 231.97 | 249.76 | 234.61 | 12.47 | 24.6 | Upgrade
|
| Net Cash (Debt) | 175.18 | 659.5 | 684.05 | 972.67 | 900.03 | Upgrade
|
| Net Cash Growth | -73.44% | -3.59% | -29.67% | 8.07% | 62.64% | Upgrade
|
| Net Cash Per Share | 0.44 | 1.66 | 1.72 | 2.42 | 2.33 | Upgrade
|
| Filing Date Shares Outstanding | 349.94 | 394.59 | 401 | 401 | 401 | Upgrade
|
| Total Common Shares Outstanding | 349.94 | 394.59 | 401 | 401 | 401 | Upgrade
|
| Working Capital | 602.05 | 884.33 | 908.49 | 968 | 969.74 | Upgrade
|
| Book Value Per Share | 4.03 | 3.59 | 3.46 | 3.44 | 3.19 | Upgrade
|
| Tangible Book Value | 1,222 | 1,221 | 1,201 | 1,213 | 1,111 | Upgrade
|
| Tangible Book Value Per Share | 3.49 | 3.09 | 2.99 | 3.02 | 2.77 | Upgrade
|
| Buildings | - | 306.04 | - | - | - | Upgrade
|
| Machinery | - | 446.91 | 391.37 | 381.13 | 383.66 | Upgrade
|
| Construction In Progress | - | 0.58 | 365.61 | 103.13 | 7.57 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.